Skip to content
Dx

HCPCS Level II · Procedures and professional services (temporary)

G2207Reason for not administering adjuvant treatment course including both chemotherapy and her2-targeted therapy (e.g. poor performance status (ecog 3-4; karnofsky <=50), cardiac contraindications, insufficient renal function, insufficient hepatic function, other active or secondary cancer diagnoses, other medical contraindications, patients who died during initial treatment course or transferred during or after initial treatment course)

✓ Active

Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.

About G2207

G2207 is an HCPCS Level II code in the G series (procedures and professional services (temporary)), describing reason for not administering adjuvant treatment course including both chemotherapy and her2-targeted therapy (e.g. poor performance status (ecog 3-4; karnofsky <=50), cardiac contraindications, insufficient renal function, insufficient hepatic function, other active or secondary cancer diagnoses, other medical contraindications, patients who died during initial treatment course or transferred during or after initial treatment course).

It was added to HCPCS effective 01/01/2021, and its current record took effect 01/01/2023.

Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.

Details

Short description
Rsn no trtmt chem her2
Date added
01/01/2021
Action effective
01/01/2023
BETOS
Z2

Related G22xx codes

Common questions about G2207

Is HCPCS G2207 still valid?

Yes. G2207 is active in the CMS October 2026 HCPCS file.

Does Medicare cover G2207?

Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.